Plus Therapeutics, Inc. (PSTV)
NASDAQ: PSTV · Real-Time Price · USD
1.160
-0.360 (-23.68%)
At close: Mar 28, 2025, 4:00 PM
1.100
-0.060 (-5.17%)
After-hours: Mar 28, 2025, 7:59 PM EDT
Plus Therapeutics Market Cap
Plus Therapeutics has a market cap or net worth of $39.37 million as of March 28, 2025. Its market cap has increased by 418.01% in one year.
Market Cap
39.37M
Enterprise Value
39.13M
1-Year Change
418.01%
Ranking
Category
Stock Price
$1.16
Market Cap Chart
Since November 16, 2000, Plus Therapeutics's market cap has decreased from $177.00M to $39.37M, a decrease of -77.76%. That is a compound annual growth rate of -5.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 6.80M | - |
| Dec 31, 2024 | 6.80M | -13.92% |
| Dec 29, 2023 | 7.90M | -26.17% |
| Dec 30, 2022 | 10.70M | -33.54% |
| Dec 31, 2021 | 16.10M | 65.98% |
| Dec 31, 2020 | 9.70M | 7.78% |
| Dec 31, 2019 | 9.00M | 136.84% |
| Dec 31, 2018 | 3.80M | -64.15% |
| Dec 29, 2017 | 10.60M | -65.81% |
| Dec 30, 2016 | 31.00M | 5.80% |
| Dec 31, 2015 | 29.30M | -35.18% |
| Dec 31, 2014 | 45.20M | -73.87% |
| Dec 31, 2013 | 173.00M | 5.10% |
| Dec 31, 2012 | 164.60M | 35.36% |
| Dec 30, 2011 | 121.60M | -53.57% |
| Dec 31, 2010 | 261.90M | 10.74% |
| Dec 31, 2009 | 236.50M | 124.17% |
| Dec 31, 2008 | 105.50M | -27.49% |
| Dec 31, 2007 | 145.50M | 18.58% |
| Dec 29, 2006 | 122.70M | -3.31% |
| Dec 30, 2005 | 126.90M | 231.33% |
| Dec 31, 2004 | 38.30M | -14.70% |
| Dec 31, 2003 | 44.90M | -13.82% |
| Dec 31, 2002 | 52.10M | 8.09% |
| Dec 31, 2001 | 48.20M | -72.77% |
View and export this data all the way back to 2000.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 737.63B |
| UnitedHealth Group | 471.74B |
| Johnson & Johnson | 393.12B |
| AbbVie | 358.61B |
| Novo Nordisk | 308.71B |
| Abbott Laboratories | 227.80B |
| AstraZeneca | 225.00B |
| Merck & Co. | 221.28B |